Masahiro Kondo Selected Research

Masahiro Kondo Research Topics

Disease

7	Pain (Aches) 01/2020 - 05/2007
4	Neoplasms (Cancer) 01/2020 - 11/2012
3	Necrosis 01/2021 - 09/2009
2	Thrombocytopenia (Thrombopenia) 02/2022 - 01/2018
2	Rheumatoid Arthritis 01/2021 - 12/2014
2	Multiple Myeloma 11/2020 - 01/2020
2	Tumor Lysis Syndrome 11/2020 - 01/2020
2	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2017
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 05/2017
2	Neutropenia 01/2018 - 11/2012
2	Hypersensitivity (Allergy) 09/2017 - 06/2008
2	Inflammation (Inflammations) 09/2017 - 01/2013
2	Osteoarthritis 01/2016 - 05/2015
2	Arthritis (Polyarthritis) 01/2015 - 01/2014
2	Facial Pain (Myofacial Pain) 01/2012 - 02/2009
1	Pneumonia (Pneumonitis) 02/2022
1	Cough 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Ascites 01/2021
1	Rheumatoid Nodule 01/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021
1	Pericardial Effusion 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 09/2018
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 09/2018
1	Hepatitis B 01/2018
1	Infections 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Urethral Neoplasms (Urethral Cancer) 05/2017
1	Solitary Kidney 05/2017
1	Inappropriate ADH Syndrome (SIADH) 05/2017
1	Dermatomyositis (Dermatopolymyositis) 10/2014
1	Experimental Arthritis 01/2014
1	Erythema 01/2014

Drug/Important Bio-Agent (IBA)

5	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 01/2007
3	Bortezomib (Velcade)FDA Link 11/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2014
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 11/2012
3	Cisplatin (Platino)FDA LinkGeneric 05/2017 - 01/2014
2	SteroidsIBA 02/2022 - 01/2021
2	tofacitinibIBA 01/2021 - 12/2014
2	Trimethoprim (Proloprim)FDA LinkGeneric 01/2020 - 01/2017
2	Thymidine Monophosphate (TMP)IBA 01/2020 - 01/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 01/2017
2	Sulfamethoxazole FDA LinkGeneric 01/2020 - 01/2017
2	Gemcitabine FDA Link 01/2018 - 05/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2012
2	Collagen Type II (Type II Collagen)IBA 01/2015 - 01/2014
2	InterleukinsIBA 12/2014 - 09/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 09/2009
2	CytokinesIBA 01/2013 - 09/2009
2	AMPA Receptors (AMPA Receptor)IBA 01/2012 - 03/2011
2	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 01/2011 - 05/2008
2	Propofol (Diprivan)FDA LinkGeneric 06/2009 - 05/2007
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	Etanercept (Enbrel)FDA Link 01/2021
1	Proteasome InhibitorsIBA 11/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020
1	Thalidomide (Thalomid)FDA Link 01/2020
1	Therapeutic UsesIBA 09/2018
1	pazopanib FDA Link 09/2018
1	Azacitidine (5 Azacytidine)FDA Link 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Drug CombinationsIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	fludarabineIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	taxaneIBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 09/2017
1	AnkyrinsIBA 09/2017
1	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 09/2017
1	tryptophyltryptophanIBA 09/2017
1	Protein Kinase C-epsilonIBA 09/2017
1	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 09/2017
1	Metabotropic Glutamate 5 ReceptorIBA 09/2017
1	Vasopressins (Vasopressin)IBA 05/2017
1	Platinum Compounds (Compounds, Platinum)IBA 05/2017
1	glycolic acid (glycolate)IBA 01/2016
1	NestinIBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 05/2015
1	Janus Kinase InhibitorsIBA 12/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2014
1	Interleukin-10 (Interleukin 10)IBA 12/2014
1	Janus KinasesIBA 12/2014
1	tocilizumab (atlizumab)FDA Link 10/2014

Therapy/Procedure

7	Therapeutics 02/2022 - 01/2018
7	Drug Therapy (Chemotherapy) 01/2020 - 11/2012
2	Renal Dialysis (Hemodialysis) 01/2018 - 11/2012
1	Plasma Exchange 02/2022
1	Antineoplastic Combined Chemotherapy Protocols 01/2018
1	Nephroureterectomy 05/2017
1	Chemoprevention 01/2017
1	Injections 01/2014